195 related articles for article (PubMed ID: 33107709)
1. Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study.
Latenstein AEJ; Dijksterhuis WPM; Mackay TM; Beijer S; van Eijck CHJ; de Hingh IHJT; Molenaar IQ; van Oijen MGH; van Santvoort HC; de van der Schueren MAE; de Vos-Geelen J; de Vries JHM; Wilmink JW; Besselink MG; van Laarhoven HWM;
Cancer Med; 2020 Dec; 9(24):9385-9395. PubMed ID: 33107709
[TBL] [Abstract][Full Text] [Related]
2. Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study.
Dijksterhuis WPM; Latenstein AEJ; van Kleef JJ; Verhoeven RHA; de Vries JHM; Slingerland M; Steenhagen E; Heisterkamp J; Timmermans LM; de van der Schueren MAE; van Oijen MGH; Beijer S; van Laarhoven HWM
J Natl Compr Canc Netw; 2021 Jan; 19(2):144-152. PubMed ID: 33418527
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
4. Comparison of resectable and unresectable periampullary carcinomas.
Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
J Am Coll Surg; 1994 Apr; 178(4):369-78. PubMed ID: 7511967
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.
; ; ; ;
Gut; 2005 Jun; 54 Suppl 5(Suppl 5):v1-16. PubMed ID: 15888770
[No Abstract] [Full Text] [Related]
7. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
8. Opportunities of improvement in the management of pancreatic and periampullary tumors.
Nordby T; Ikdahl T; Lothe IM; Ånonsen K; Hauge T; Edwin B; Line PD; Labori KJ; Buanes T
Scand J Gastroenterol; 2013 May; 48(5):617-25. PubMed ID: 23597153
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study.
van Hooft JE; Uitdehaag MJ; Bruno MJ; Timmer R; Siersema PD; Dijkgraaf MG; Fockens P
Gastrointest Endosc; 2009 May; 69(6):1059-66. PubMed ID: 19152912
[TBL] [Abstract][Full Text] [Related]
10. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
12. [Second-look operation in pancreatic carcinoma previously assessed as unresectable].
Warnick P; Bahra M; Andreou A; Neuhaus P; Glanemann M
Zentralbl Chir; 2010 Feb; 135(1):70-4. PubMed ID: 20162503
[TBL] [Abstract][Full Text] [Related]
13. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
15. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapy of pancreatic and periampullary carcinoma in elderly patients].
Benhidjeb T; Zanow J
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():489-91. PubMed ID: 9101908
[TBL] [Abstract][Full Text] [Related]
18. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
20. Impact of staging on treatment of pancreatic and ampullary cancer.
Karl RC; Carey LC
Endoscopy; 1993 Jan; 25(1):69-74. PubMed ID: 8384102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
